-
Mashup Score: 0Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure - 1 year(s) ago
This cross-sectional study estimates out-of-pocket costs of heart failure with reduced ejection fraction medication regimens in Medicare Part D under current law and the Inflation Reduction Act.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4JCF Heart Failure Year-In-Review 2022… The Best is Yet to Come! - 1 year(s) ago
2022 was a year of groundbreaking scientific advances for the heart failure (HF) community at large. Several landmark trials were presented and/or published that will have a significant impact on clinical practice. As we reflect on this productive year, we wanted to take the opportunity to summarize key results for some of these practice-changing trials, while highlighting important initiatives…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet-
What year 2022 was in #FunctionNotFailure!! Check out our @JCardFail January Ed page led by @vbluml summarizing 🔑 trials in our field & specific JCF papers & initiatives!Looking forward to innovation & discovery in 2023! @robmentz https://t.co/VCySSnfQrF https://t.co/Zc0mnbrPNT https://t.co/Qasj95ipAq
-
-
Mashup Score: 8Omecamtiv mecarbil: Decisional Dilemmas & Regulatory Science – Opportunities for Improvement? - 1 year(s) ago
The Food and Drug Administration (FDA) is required to make decisions that can at times be controversial, for a myriad of reasons, on the benefits versus risks for medical products. This is understandable as science accelerates but with a suboptimal or more complex evidence generation system. For guidance on some of these decisions, the FDA occasionally asks an advisory committee to weigh in on…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet-
Unique 💡insight from @texhern @DCRINews as to @US_FDA advisory board decision on #OmecamtivMecarbil & opportunities that lie ahead👇🏽 As always @JCardFail strives to be your home for all things #FunctionNotFailure promoting constructive discourse 🗣️ https://t.co/iiJTs1RfR7 https://t.co/wadMmi3IHW https://t.co/tgnq52WhvQ
-
-
Mashup Score: 8Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come - 1 year(s) ago
Abstract. What was once considered a topic best avoided, managing heart failure with reduced ejection fraction (HFrEF) has become the focus of many drug and dev
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 11Discordance of Pressure and Volume: Potential Implications for Pressure-Guided Remote Monitoring in Heart Failure - 2 year(s) ago
The monitoring and treatment of congestion are key pillars of modern heart failure (HF) management. Intravascular volume derangement in HF is a well-recognized problem; however, the routine assessment of congestion poses challenges in clinical practice as the signs and symptoms are neither sensitive nor specific.1 In fact, no commonly used surrogate of volume status (ie, physical signs,…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 8Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future - 2 year(s) ago
The 1912 Nobel prize in Medicine and Physiology was given to Alexis Carrel for his work on the anastomosis of blood vessels, which formed the basis for organ transplantation. It is claimed he prophesied that “the ideal method would be to transplant in man organs of animals easy to secure and operate on, such as hogs, for instance. But it would in all probability be necessary to immunize organs of…
Source: Journal of Cardiac FailureCategories: Cardiologists, Latest HeadlinesTweet-
One stop 🛑shop for 🔥topic : donation after circulatory death w/recent article in @nytimes to this effect also!!! The field of 🫀#transplant is stagnant no longer…#FunctionNotFailure Also ICYMI: 👀check out https://t.co/1o10hxS2Ag on #xenotransplant @MRMehraMD https://t.co/gfSFEhIHY5 https://t.co/a6wrvreJ7y
-
-
Mashup Score: 5A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction: - 2 year(s) ago
Abstract Objectives This study sought to estimate and compare the aggregate treatment benefit of pharmacological therapy for heart failure (HF) with reduced ejection fraction. Background The estima…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 9
Abstract Background There is growing interest to disentangle worsening heart failure (WHF) from location of care and move away from hospitalization as a surrogate for acuity. Objectives The purpose…
Categories: Expert Picks, Latest HeadlinesTweet-
New data out in #JACC on #HeartFailure events! The UTILIZE-WHF study found ED visits/observation stays and outpatient encounters account for most worsening heart failure events and portend a poor short-term prognosis. https://t.co/vgCJgYSD1S #CardioTwitter #FunctionNotFailure https://t.co/NPwkMBormo
-
-
Mashup Score: 25Alcohol may be more risky to the heart than previously thought - 2 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 12Burden of Pediatric Heart Failure in the United States: - 2 year(s) ago
Abstract Background There are currently limited accurate national estimates for pediatric heart failure (HF). Objectives This study aims to describe the current burden of primary and comorbid pedia…
Categories: Expert Picks, Latest HeadlinesTweet
Nice piece by @MicahJohnsonMD and colleagues on out of pocket costs for #GDMT in HFrEF Important consideration that does not get enough attention when discussing optimal med regimen! #FunctionNotFailure https://t.co/CIea23WhRR https://t.co/1dj0bsmXmd